These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11311486)

  • 1. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation.
    Uesato S; Kitagawa Y; Kaijima T; Tokuda H; Okuda M; Mou XY; Mukainaka T; Nishino H
    Cancer Lett; 2001 May; 166(2):143-6. PubMed ID: 11311486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
    Uesato S; Kitagawa Y; Hara Y; Tokuda H; Okuda M; Mou XY; Mukainaka T; Nishino H
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1673-5. PubMed ID: 10937722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
    Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of monoacylated 2-O-beta-galactosylglycerols on Epstein-Barr virus activation: the significant role of the hexanoyl chain.
    Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Mukainaka T; Nagatsu A; Konoshima T; Tokuda H; Nishino H
    Cancer Lett; 1999 Aug; 143(1):1-4. PubMed ID: 10465330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids with a branched-acyl chain.
    Tai A; Kawasaki D; Sasaki K; Gohda E; Yamamoto I
    Chem Pharm Bull (Tokyo); 2003 Feb; 51(2):175-80. PubMed ID: 12576651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein-Barr virus activation.
    Tamura S; Fukamiya N; Okano M; Tokuda H; Aoi W; Mukainaka T; Nishino H; Tagahara K; Koike K
    Cancer Lett; 2002 Nov; 185(1):47-51. PubMed ID: 12142078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.
    Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H
    Cancer Lett; 2002 Dec; 186(1):37-41. PubMed ID: 12183073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the epstein-barr virus early antigen activation.
    Motohashi N; Yamagami C; Tokuda H; Okuda Y; Ichiishi E; Mukainaka T; Nishino H; Saito Y
    Mutat Res; 2000 Jan; 464(2):247-54. PubMed ID: 10648911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeation and metabolism of a series of novel lipophilic ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids with a branched-acyl chain, in a human living skin equivalent model.
    Tai A; Goto S; Ishiguro Y; Suzuki K; Nitoda T; Yamamoto I
    Bioorg Med Chem Lett; 2004 Feb; 14(3):623-7. PubMed ID: 14741256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic and branched acyl chain galactoglycerolipids and their effect on anti-tumor-promoting activity.
    Colombo D; Franchini L; Toma L; Ronchetti F; Tanaka R; Takayasu J; Nishino H; Tokuda H
    Eur J Med Chem; 2006 Dec; 41(12):1456-63. PubMed ID: 16996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation.
    Yamamoto Y; Miura Y; Kinoshita Y; Higuchi M; Yamada Y; Murakami A; Ohigashi H; Koshimizu K
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1388-90. PubMed ID: 7553984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of naphthoquinones.
    Koyama J; Morita I; Kobayashi N; Osakai T; Hotta H; Takayasu J; Nishino H; Tokuda H
    Cancer Lett; 2003 Nov; 201(1):25-30. PubMed ID: 14580683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
    Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
    Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of Epstein-Barr virus activation by Citrus fruits, a cancer chemopreventor.
    Iwase Y; Takemura Y; Ju-ichi M; Kawaii S; Yano M; Okuda Y; Mukainaka T; Tsuruta A; Okuda M; Takayasu J; Tokuda H; Nishino H
    Cancer Lett; 1999 May; 139(2):227-36. PubMed ID: 10395183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives.
    Koyama J; Inoue M; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
    Cancer Lett; 2006 Sep; 241(2):263-7. PubMed ID: 16338070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.
    Yamamoto I; Tai A; Fujinami Y; Sasaki K; Okazaki S
    J Med Chem; 2002 Jan; 45(2):462-8. PubMed ID: 11784150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Allergic Activity of Monoacylated Ascorbic Acid 2-Glucosides.
    Miura K; Morishita Y; Matsuno H; Aota Y; Ito H; Tai A
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29231858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.
    Konoshima T; Takasaki M; Tatsumoto T; Kozuka M; Kasai R; Tanaka O; Nie RL; Tokuda H; Nishino H; Iwashima A
    Biol Pharm Bull; 1994 May; 17(5):668-71. PubMed ID: 7920430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervening effect of L-ascorbic acid on Epstein-Barr virus activation in human lymphoblastoid cells and its comparison with the effect of retinoic acid.
    Morigaki T; Ito Y
    Cancer Lett; 1982; 15(3):255-9. PubMed ID: 6288231
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycoglycerolipid analogues active as anti-tumor-promoters: the influence of the anomeric configuration.
    Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Tokuda H; Nishino H
    Eur J Med Chem; 2000 Dec; 35(12):1109-13. PubMed ID: 11248409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.